What is Mirador Therapeutics worth?
$1.0Blast known valuation
Mirador Therapeutics last raised $333.0M in its Later Stage VC (Feb 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Mirador Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2024 | Later Stage VC | $333.0M | ▮ | ▮ |
| Dec 2023 | Later Stage VC | $80.0M | ▮ | ▮ |
How Mirador Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Mirador Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Mirador Therapeutics worth?
- Mirador Therapeutics's last known valuation is $1.0B.
- How much has Mirador Therapeutics raised?
- Mirador Therapeutics has raised $735.0M in total funding across 2 recorded rounds.
- When did Mirador Therapeutics last raise?
- Mirador Therapeutics last raised in Feb 2024 (Later Stage VC), raising $333.0M.